Clinical Trial Update: Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the pharmacokinetics, safety, and preliminary efficacy of a nanoparticle paclitaxel in patients with peritoneal neoplasms; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Neoplasms

Drugs mentioned

• Nanoparticle Paclitaxel (paclitaxel (nanoparticle formulation))

Snippet

Sponsor: CritiTech, Inc. | Conditions: Peritoneal Neoplasms | Phase 1 | Status: COMPLETED